![](http://t.guardian.ng/wp-content/uploads/2024/06/AFP__20240318__34J33MN__v1__Preview__UsHealthSickleCell-1024x683.jpg)
Experts report toxicity reduction in polymeric prodrug pre-clinical trials
Preclinical studies have shown that a newly developed polymeric prodrug when administered subcutaneously (SC), reduces the production of hemotoxic metabolites in the liver and the risk of hemolytic anemia, thereby potentially modifying